Clarity Pharma Limited company information, Employees & Contact Information

Clarity Pharma Co-PSMA Trial Meets Main Goal, Detects More Prostate Cancer Lesions Than Standard One Nasdaq

Clarity Pharmaceuticals says it will be 'unaffected' by US pharma tariffs Capital Brief

ASX Penny Stocks Spotlight: Clarity Pharmaceuticals And 2 More Standouts Yahoo Finance

Lander & Rogers advises Clarity Pharmaceuticals on $203 million equity raise Lander & Rogers

Clarity Pharma Unaffected by Trump’s Tariffs Sharecafe

Capricor sees FDA 'clarity' on path for DMD cell therapy after surprise rejection FirstWord Pharma

Clarity Pharma shares rally on $203m institutional placement Capital Brief

Pharma makes Cannes Lions comeback with 'brilliant basics' Fierce Pharma

What the market's missing on Clarity Pharmaceuticals Livewire Markets

Greatland Resources, Clarity Pharma headline huge ASX 200 rebalance AFR

Clarity Pharma shares swing into red despite 'positive' trial results Capital Brief

Indoco Remedies partners with Clarity Pharma to launch 20 products in UK market CNBC TV18

A defining opportunity for clarity from GS1 Express Pharma

LENZ bags FDA nod for presbyopia eye drop Vizz FirstWord Pharma

Trump’s push to onshore pharma manufacturing clouded by ‘lack of clarity’ Pharmaceutical Technology

Clarity and Cardinal Health enter into Agreement for Targeted Copper Theranostics Cardinal Health

FDA looks to clarify confirmatory trial mandate for accelerated approvals Fierce Pharma

Clarity Pharma rallies after completing enrolment for diagnostic study Capital Brief

Clarity Pharma shares jump on new diagnostic trial results Capital Brief

Clarity Pharmaceuticals receives second FDA review for prostate cancer diagnostic Capital Brief

individual investors who own 51% along with institutions invested in Clarity Pharmaceuticals Ltd (ASX:CU6) saw increase in their holdings value last week simplywall.st

Clarity and Evergreen Enter Clinical Manufacturing Agreement Contract Pharma

Pharma giants push for tariff clarity as ambiguity threatens EU-U.S. deal CNBC

We Think Clarity Pharmaceuticals (ASX:CU6) Can Easily Afford To Drive Business Growth simplywall.st

Clarity Pharmaceuticals (ASX:CU6) Is Down 5.2% After PSMA Imaging Trial Hits Primary Endpoint Has The Bull Case Changed? simplywall.st

INDOCO PARTNERS WITH CLARITY PHARMA FOR DISTRIBUTION ICICI Direct

FDA’s PreCheck: pharma industry calls for clarity in 30 Sep public meeting Lexology

Is FDA approval next for Clarity Pharmaceuticals? ig.com

Trump's pharmaceutical tariffs materialize at last in new US-EU trade deal Fierce Pharma

Clarity Pharmaceuticals launches $121 million fully underwritten equity raising BiotechDispatch

GDPR Clarity For Pharma: Industry Code Nears EU-Wide Approval After Six-Year Journey Citeline News & Insights

Lantern Pharma Announces Completion of Type C Meeting with FDA, Providing Clarity on Regulatory Pathway for Pediatric CNS Cancer Trial Business Wire

‘Good news’ for pharma companies as UPC provides clarity on imminent infringement Pinsent Masons

Clarity Pharmaceuticals (ASX:CU6) is off all time highs but is a $600m company! Is it the next Telix? Stocks Down Under

The scientist-turned-banker’s mission to fund cancer breakthrough AFR

Radiopharmaceutical emerges as the hottest space in biotech; here's what it means for Clarity Pharma Stockhead

Eisai secures FDA green light for Leqembi autoinjector, teeing up at-home maintenance dosing Fierce Pharma

The drug dealer’s den that forged a billion-dollar biotech The Australian

CSL, Telix lead biotech selloff after Eli Lilly tanks on Wall Street Capital Brief

Clarity Pharmaceuticals (ASX:CU6): Evaluating Valuation Following Breakthrough Co-PSMA Trial Results simplywall.st

Clarity Pharma charges ahead on ASX debut AFR

Clarity Pharma’s SECuRE Trial Shows Promise Sharecafe

Australian startups take on big pharma with precision cancer breakthroughs Forbes Australia

ASX Health Stocks: Clarity Pharma says its prostate cancer treatment has achieved 'complete response' Stockhead

Incyte picks Dr. Pimple Popper to expand Opzelura atopic dermatitis campaign Fierce Pharma

Ardelyx axes 65% of workforce with no clarity from FDA on kidney drug's future Fierce Pharma

Health Check: Clarity shares surge after ‘fast and sizeable’ $203m raise Stockhead

Ahead of strategy reveal, Bayer taps activist investor Jeffrey Ubben for board seat Fierce Pharma

Clarity and value of distribution partners beyond pick, pack and ship Fierce Pharma

Dr Boreham's Crucible: Clarity is a clear and strong contender in the prostate cancer treatment race Stockhead

Three ASX companies jockeying to be the next biotech winners AFR

Firm advises Clarity Pharmaceuticals on $121 million equity raise Lander & Rogers

University welcomes largest pure biotech IPO in ASX history The University of Melbourne

Incyte taps actor Mandy Moore to help tell the stories of eczema patients, with focus on teen's Opzelura experience Fierce Pharma

Tariffed or not? Uneasy calm prevails over pharma industry as it looks for clarity from the US BusinessLine

Clarity Pharmaceuticals Shares (ASX: CU6) Deliver A Year of Two Halves thebull.com.au

Safety looms large in full data reveal for Alzheimer's hopeful lecanemab FirstWord Pharma

Heron's opioid alternative Zynrelef, slated for blockbuster status, hits a rough Q4 as Jefferies seek 'launch clarity' Fierce Pharma

Why Clarity Pharmaceuticals, GQG Partners, Light & Wonder, and QBE shares are dropping today The Motley Fool Australia

Health stocks jittery over US pharma tariffs, new investigation The Australian

Does Pfizer really want Bristol-Myers? Likely, says one analyst. What's it waiting for? Fierce Pharma

The 30 fastest-growing unquoted pharma companies in the UK Consultancy.uk

Clarity Pharmaceuticals (ASX: CU6) The Motley Fool Australia